Puthupparampil V Scaria - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Puthupparampil V Scaria

Showing results (11-20 of 20) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 20 results.

Plos One|December 28, 2017

Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicityPuthupparampil V Scaria, Beth Chen, Christopher G Rowe, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|June 28, 2005

Transporting silence: design of carriers for siRNA to angiogenic endotheliumRaymond M Schiffelers, Archibald J Mixson, Aslam M Ansari, et al.

Vaccine|July 1, 2020

Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230Puthupparampil V Scaria, Beth B Chen, Christopher G Rowe, et al.

NPJ Vaccines|January 6, 2024

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune responsePuthupparampil V Scaria, Nicole Roth, Kim Schwendt, et al.

NPJ Vaccines|July 18, 2019

Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230Puthupparampil V Scaria, Christopher G Rowe, Beth B Chen, et al.

NPJ Vaccines|December 10, 2021

Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaquesPuthupparampil V Scaria, Charles Anderson, Olga Muratova, et al.

The Journal of Clinical Investigation|February 9, 2021

Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not miceSara A Healy, Charles Anderson, Bruce J Swihart, et al.

Vaccines|June 27, 2025

SARS-CoV-2 Receptor Binding Domain (RBD) Protein-Protein Conjugate Induces Similar or Better Antibody Responses as Spike mRNA in Rhesus MacaquesPuthupparampil V Scaria, Christopher G Rowe, Ivan Kosik, et al.

Oncotarget|August 24, 2014

Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastomaNegar Babae, Meriem Bourajjaj, Yijia Liu, et al.

Lab Animal|November 6, 2023

Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.

Pageof 2

Search research articles

Showing results (11-20 of 20) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 20 results.

Plos One|December 28, 2017

Protein-protein conjugate nanoparticles for malaria antigen delivery and enhanced immunogenicityPuthupparampil V Scaria, Beth Chen, Christopher G Rowe, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|June 28, 2005

Transporting silence: design of carriers for siRNA to angiogenic endotheliumRaymond M Schiffelers, Archibald J Mixson, Aslam M Ansari, et al.

Vaccine|July 1, 2020

Comparison of carrier proteins to conjugate malaria transmission blocking vaccine antigens, Pfs25 and Pfs230Puthupparampil V Scaria, Beth B Chen, Christopher G Rowe, et al.

NPJ Vaccines|January 6, 2024

mRNA vaccines expressing malaria transmission-blocking antigens Pfs25 and Pfs230D1 induce a functional immune responsePuthupparampil V Scaria, Nicole Roth, Kim Schwendt, et al.

NPJ Vaccines|July 18, 2019

Outer membrane protein complex as a carrier for malaria transmission blocking antigen Pfs230Puthupparampil V Scaria, Christopher G Rowe, Beth B Chen, et al.

NPJ Vaccines|December 10, 2021

Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaquesPuthupparampil V Scaria, Charles Anderson, Olga Muratova, et al.

The Journal of Clinical Investigation|February 9, 2021

Pfs230 yields higher malaria transmission-blocking vaccine activity than Pfs25 in humans but not miceSara A Healy, Charles Anderson, Bruce J Swihart, et al.

Vaccines|June 27, 2025

Oncotarget|August 24, 2014

Systemic miRNA-7 delivery inhibits tumor angiogenesis and growth in murine xenograft glioblastomaNegar Babae, Meriem Bourajjaj, Yijia Liu, et al.

Lab Animal|November 6, 2023

Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSAJustin Doritchamou, Morten A Nielsen, Arnaud Chêne, et al.

Pageof 2